# ARIAD PHARMACEUTICALS INC

ARIAD PHARMACEUTICALS INC is a company headquartered in Cambridge, MA, United States.

## Company overview

- **Legal name:** ARIAD PHARMACEUTICALS INC
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Cambridge, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0000884731

## About

ARIAD PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000884731, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2016-02-29, it reported annual revenue of USD 118,804,000; net income of USD -231,156,000; total assets of USD 546,692,000 for the fiscal period ended 2015-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2015 (period ended 2015-12-31)

- **Revenue:** $118.8M (USD 118,804,000)
- **Net income:** -$231.2M (USD -231,156,000)
- **Total assets:** $546.7M (USD 546,692,000)
- **Cash and equivalents:** $230.9M (USD 230,888,000)

### FY2014 (period ended 2014-12-31)

- **Revenue:** $105.4M (USD 105,412,000)
- **Net income:** -$162.6M (USD -162,602,000)
- **Total assets:** $603.9M (USD 603,870,000)
- **Cash and equivalents:** $352.7M (USD 352,688,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2013 (period ended 2013-12-31)

- **Revenue:** $45.6M (USD 45,561,000)
- **Net income:** -$274.2M (USD -274,158,000)
- **Total assets:** $370.9M (USD 370,894,000)
- **Cash and equivalents:** $237.2M (USD 237,179,000)
- **Operating cash flow:** -$221.9M (USD -221,882,000)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $558,000 (USD 558,000)
- **Net income:** -$220.9M (USD -220,872,000)
- **Total assets:** $180.2M (USD 180,193,000)
- **Cash and equivalents:** $119.4M (USD 119,379,000)
- **Operating cash flow:** -$153.7M (USD -153,681,000)

## Recent SEC filings

- Form 8-K — filed 2017-02-16 — period 2017-02-16 — FORM 8-K
- Form SC 13G — filed 2017-02-14
- Form SC 13G — filed 2017-02-09 — SEC SCHEDULE 13G
- Form 8-K — filed 2017-02-06 — period 2017-02-06 — ARIAD PHARMACEUTICALS, INC. 8-K
- Form SC 13D — filed 2017-01-18 — SC 13D
- Form 8-K — filed 2017-01-10 — period 2017-01-08 — 8-K
- Form 8-K — filed 2016-12-08 — period 2016-12-05 — ARIAD PHARMACEUTICALS, INC. 8-K
- Form 8-K — filed 2016-12-07 — period 2016-12-01 — 8-K
- Form 8-K — filed 2016-11-30 — period 2016-11-29 — ARIAD PHARMACEUTICALS, INC. 8-K
- Form 8-K — filed 2016-11-18 — period 2016-11-16 — ARIAD PHARMACEUTICALS, INC. 8-K
- Form 10-Q — filed 2016-11-08 — period 2016-09-30 — 10-Q Q3 2016 FILING
- Form 8-K — filed 2016-11-07 — period 2016-11-07 — ARIAD PHARMACEUTICALS, INC. 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/ariad-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology